135 related articles for article (PubMed ID: 22810102)
1. Highly pathogenic Alzheimer's disease presenilin 1 P117R mutation causes a specific increase in p53 and p21 protein levels and cell cycle dysregulation in human lymphocytes.
Bialopiotrowicz E; Szybinska A; Kuzniewska B; Buizza L; Uberti D; Kuznicki J; Wojda U
J Alzheimers Dis; 2012; 32(2):397-415. PubMed ID: 22810102
[TBL] [Abstract][Full Text] [Related]
2. Increase in p53 protein levels by presenilin 1 gene mutations and its inhibition by secretase inhibitors.
Ma L; Ohyagi Y; Miyoshi K; Sakae N; Motomura K; Taniwaki T; Furuya H; Takeda K; Tabira T; Kira J
J Alzheimers Dis; 2009; 16(3):565-75. PubMed ID: 19276551
[TBL] [Abstract][Full Text] [Related]
3. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
[TBL] [Abstract][Full Text] [Related]
4. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
5. Familial Alzheimer's Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants.
Wojsiat J; Laskowska-Kaszub K; Alquézar C; Białopiotrowicz E; Esteras N; Zdioruk M; Martin-Requero A; Wojda U
Mol Neurobiol; 2017 Sep; 54(7):5683-5698. PubMed ID: 27644130
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle-driven neuronal apoptosis specifically linked to amyloid peptide Abeta1-42 exposure is not exacerbated in a mouse model of presenilin-1 familial Alzheimer's disease.
Malik B; Currais A; Soriano S
J Neurochem; 2008 Jul; 106(2):912-6. PubMed ID: 18466334
[TBL] [Abstract][Full Text] [Related]
7. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
[TBL] [Abstract][Full Text] [Related]
8. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients.
Bialopiotrowicz E; Kuzniewska B; Kachamakova-Trojanowska N; Barcikowska M; Kuznicki J; Wojda U
Neurobiol Aging; 2011 Dec; 32(12):2319.e13-26. PubMed ID: 20541838
[TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
11. The presenilin 1 C92S mutation increases abeta 42 production.
Lewis PA; Perez-Tur J; Golde TE; Hardy J
Biochem Biophys Res Commun; 2000 Oct; 277(1):261-3. PubMed ID: 11027672
[TBL] [Abstract][Full Text] [Related]
12. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
[TBL] [Abstract][Full Text] [Related]
13. Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of γ-secretase activity in endogenous amyloid-β generation.
Koch P; Tamboli IY; Mertens J; Wunderlich P; Ladewig J; Stüber K; Esselmann H; Wiltfang J; Brüstle O; Walter J
Am J Pathol; 2012 Jun; 180(6):2404-16. PubMed ID: 22510327
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors.
Miyoshi K; Ohyagi Y; Sakae N; Motomura K; Ma L; Taniwaki T; Furuya H; Tabira T; Kira J
J Alzheimers Dis; 2009; 16(3):551-64. PubMed ID: 19276550
[TBL] [Abstract][Full Text] [Related]
15. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
16. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
17. Relative ratio and level of amyloid-β 42 surrogate in cerebrospinal fluid of familial Alzheimer disease patients with presenilin 1 mutations.
Tagami S; Okochi M; Yanagida K; Kodama T; Arai T; Kuwano R; Ikeuchi T; Takeda M
Neurodegener Dis; 2014; 13(2-3):166-70. PubMed ID: 24192669
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
19. Clinical-genetic correlations in familial Alzheimer's disease caused by presenilin 1 mutations.
Gómez-Tortosa E; Barquero S; Barón M; Gil-Neciga E; Castellanos F; Zurdo M; Manzano S; Muñoz DG; Jiménez-Huete A; Rábano A; Sainz MJ; Guerrero R; Gobernado I; Pérez-Pérez J; Jiménez-Escrig A
J Alzheimers Dis; 2010; 19(3):873-84. PubMed ID: 20157243
[TBL] [Abstract][Full Text] [Related]
20. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
